Initiator Pharma: Positive Pharmacokinetic Results

Research Note



Redeye is encouraged to learn that Initiator Pharma has obtained positive data from its phase I drug formulation and pharmacokinetics study with pudafensine (IP2015).


Kevin Sule

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.